Lancet Study Praises China, Criticizes India In Handling MDR TB Spread
This article was originally published in PharmAsia News
Executive Summary
India received praise in a global study of multi-drug-resistant tuberculosis for making the disease a notifiable one, but criticized the private sector for failing to detect the disease in many patients.